MINERAL WELLS, Texas–(BUSINESS WIRE)–Alpha-Stim, cranial electrotherapy stimulation (CES) devices providing treatment for anxiety, depression, insomnia and pain, announces its user-supported campaign to change an FDA rule regarding Pre-Market Approval (PMA), the medical device equivalent of a new drug application. FDA is proposing a rule that would now require PMA for CES, while for the past 30 years CES devices have been legally cleared to market in the USA by FDA….
http://www.businesswire.com/news/home/20111025005700/en/Leading-Innovator-Alpha-Stim-Gains-Support-Medical-Professionals